welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
terminated
A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP)
study id #: NCT00140894
condition: Adenomatous Polyposis Coli
status: terminated
purpose:A study to evaluate rofecoxib in the treatment of rectal, colon, or duodenal adenomas in patients with Familial Adenomatous Polyposis.
intervention:
Drug: MK0966; rofecoxib / Duration of Treatment: 24 weeks
Drug: Comparator: placebo / Duration of Treatment: 24 weeks
study details
study contacts
expertly curated content related to this topic
-
Ileal Pouch Anal Anastomosis: An Overview of Surgery, Recovery, and Achieving Postsurgical ContinenceIleal pouch anal anastomosis (IPAA) is a...
-
Dear Ostomy: Answering Some Ostomy Questionshttps://www.youtube.com/watch?v=CaiPkf9i...
-
Minimal Access Laparoscopic Surgery for Treatment of Ulcerative Colitis and Familial Adenomatous Polyposis Coli in C...BACKGROUND : Laparoscopic restorative pr...
-
Revealing the Power of the Rare Disease Community With State-of-the Art Collaborative, Trustworthy, Digital Educatio...The growth of online communities in ...
-
Hereditary Colorectal Cancer Syndromes and Genetic TestingColorectal cancer (CRC) is a leading cau...
-
Non-Surgical Management of Attenuated and Deleterious (Classical) Familial Adenomatous Polyposis: A Long-term Survei...The primary objective of this chart revi...
-
Curcumin for the Prevention of Polyps for FAPhttps://www.youtube.com/watch?v=e7EGeVTB...
English
Portuguese
Spanish